DNA-PKcs促进神经母细胞瘤治疗耐药性和转移性复发
Mahnaz Norouzi1, Subin Kim1, Beibei Zhu2
1Markey Cancer Center, University of Kentucky, Lexington, KY.
Cancer letters
|March 1, 2026
概括
与低剂量放射治疗相结合的DNA-PKcs抑制有效地治疗高危神经母细胞瘤. 这种策略可以防止瘤复发和自我更新,与基于化疗的治疗不同.
科学领域:
- 在瘤学瘤学.
- 癌症生物学 癌症生物学
- 辐射疗法 辐射疗法
背景情况:
- 高危神经母细胞瘤的预后不好,经常发生远程复发.
- 转移性复发是神经母细胞瘤患者的主要死亡原因.
- 针对复发机制对于提高生存率至关重要.
研究的目的:
- 确定DNA-PKcs作为神经母细胞瘤中生存率低下和转移性复发的决定因素.
- 比较化疗与放射治疗结合DNA-PKcs抑制在减少转移负担和预防复发方面的疗效.
主要方法:
- 利用殖民地形成试验来评估神经母细胞瘤细胞对不同治疗的反应.
- 研究了DNA-PKcs抑制与多克索鲁比辛 (化疗) 和低剂量放射治疗的协同效应.
- 在神经母细胞瘤转移模型中评估治疗结果.
主要成果:
- 神经母细胞瘤殖民地单独抵抗多克索鲁比,需要高剂量多克索鲁比加DNA-PKcs抑制.
- 低剂量放射治疗与DNA-PKcs抑制相结合,有效控制了殖民地进展.
- 放射治疗和DNA-PKcs抑制之间的最大协同作用发生在抑制剂在辐射后4小时内给予时.
- 慢性多克索鲁比辛和佩波塞尔蒂布导致治疗耐药的细胞.
- 慢性放射治疗和peposertib破坏了神经母细胞瘤的自我更新,并防止了长期的殖民地维护.
- 在转移中,多克索鲁比加DNA-PKcs抑制显示出有限的疗效和副作用.
- 低剂量,分离放射治疗加上DNA-PKcs抑制实现了全损伤回归,损害了自我更新,并避免了全身不良影响.
结论:
- 较高的DNA-PKcs水平与神经母细胞瘤患者的预后不佳相关.
- 低剂量放射治疗与peposertib结合,比化疗更有效地废除神经母细胞瘤自我更新.
- DNA-PKcs是转移性复发的关键媒介.
- 放射治疗加上DNA-PKcs抑制是治疗复发性或耐火性高风险神经母细胞瘤的有希望的策略.
更多相关视频
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
8.0K
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
2.2K
相关概念视频
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:50Combination Therapies and Personalized Medicine
6.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.3K
02:23Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K